Stock comparison
Harmony Biosciences Holdings
HRMY$2.22BHealthcare Market cap, Sector
SANOFI CONS HEALTHC IND L
SANOFICONR.NS$102.51BHealthcare Market cap, Sector
Overall winner
SANOFI CONS HEALTHC IND L
HRMY 07 SANOFICONR.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
HRMY0wins
7winsSANOFICONR.NS
67C
B78
61C
A89
75B
B83
62C
B77
28F
A91
62C
A86
67C
A85
Side-by-side metrics
| Metric | HRMY | SANOFICONR.NS |
|---|---|---|
| Market cap | $2.22B | $102.51B Winner |
| P/E (TTM) | Winner: 12.5x | 44.2x |
| EV/EBIT | Winner: 6.9x | 31.8x |
| ROIC (TTM) | 12.5% | 59.15% Winner |
| Gross margin | Winner: 76.55% | 68.13% |
| Net margin | 16.2% | 27.35% Winner |
| Revenue CAGR 5y | Winner: 29.85% | 27.01% |
| EPS CAGR 5y | Winner: 46.45% | 20.67% |
| Debt / Equity | 0.2x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HRMY leads on
- EV/EBIT6.9xvs 31.8x+78%
- P/E (TTM)12.5xvs 44.2x+72%
- EPS CAGR 5y46.45%vs 20.67%+56%
- Gross margin76.55%vs 68.13%+11%
SANOFICONR.NS leads on
- Market cap$102.51Bvs $2.22B+98%
- ROIC (TTM)59.15%vs 12.5%+79%
- Debt / Equity0.1xvs 0.2x+72%
- Net margin27.35%vs 16.2%+41%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.